Category
page 1Pharmaceuticals policy
antimicrobial resistance
resistance of microbes to drugs directed against them
generic drug
pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use
medical cannabis
marijuana used medicinally
over-the-counter drug
medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may only be sold to consumers possessing a valid prescription
good manufacturing practice
the practices required in order to conform to the quality guidelines recommended by regulatory agencies that control the authorization and licensing of the manufacture and sale of certain consumer and medical products
prescription drug
medication legally requiring a medical prescription before it can be dispensed
orphan drug
regulatory class of pharmaceutical drug
pharmacovigilance
Pharmacovigilance (PV, or PhV), also known as drug safety, is the discipline within pharmaceutical science that addresses the identification, evaluation, and mitigation of adverse effects and other drug-related problems associated with pharmaceutical products.
regulation of therapeutic goods
regulation designed mainly to protect the health and safety of the population, aiming at ensuring the safety, quality, and efficacy of the therapeutic goods
multidrug-resistant tuberculosis
tuberculosis that is resistant to isoniazid and rifampicin, the two most powerful first-line anti-TB drugs
counterfeit medication
medication or pharmaceutical item which is produced and sold with the intent to deceptively represent its origin, authenticity or effectiveness
The Constant Gardener
2001 novel by John le Carré
International Union of Basic and Clinical Pharmacology
organization
contract research organization
type of healthcare company
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Initiative to promote public health
Federal Food, Drug, and Cosmetic Act
acts of the United States Congress that authorized the Food and Drug Administration to oversee the safety of food, drugs, medical devices, and cosmetics
online pharmacy
pharmacy that operates over the Internet
traceability
Traceability is the capability to trace something. In some cases, it is interpreted as the ability to verify the history, location, or application of an item by means of documented recorded identification.
antibiotic misuse
misuse or overuse of antibiotics, with potentially serious effects on health
Common Technical Document
internationally agreed format for drug approvals
drug nomenclature
pharmacological drug nomenclature
Antibiotic use in livestock
use of antibiotics for any purpose in the husbandry of livestock
Clinical Trials Directive
European Union Directive (EU) 2001/20
formulary
list of medicines; collection of formulas for the compounding and testing of medication
Elixir sulfanilamide
Improperly prepared sulfanilamide medicine that caused mass poisoning in the US in 1937
EudraLex
EudraLex is the collection of rules and regulations governing medicinal products in the European Union.
vaccination policy
health policy in relation to vaccination
Swissmedic
thumb|Logo of Swissmedic
The Swiss Agency for Therapeutic Products (Swissmedic) is the Swiss surveillance authority for medicines and medical devices, registered in Bern. It began operations on 1 January 2002 as successor of (IKS), which was itself the successor of (SANZ). Swissmedic is affiliated to the Federal Department of Home Affairs.
Council for International Organizations of Medical Sciences
international non-governmental organization (NGO) dealing with ethics of health-related research

Side Effects
2005 film by Kathleen Slattery-Moschkau
vaccine resistance
adaptation of pathogens to reduce the protection of vaccines
Directive 2001/83/EC
European Union Directive (EU) 2001/83
postmarketing surveillance
practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market
EudraVigilance
EudraVigilance (European Union Drug Regulating Authorities Pharmacovigilance) is the European data processing network and management system for reporting and evaluation of suspected adverse reactions to medicines or devices which have received marketing authorisation or are actively being studied in clinical trials in the European Economic Area (EEA). The European Medicines Agency (EMA) operates the system on behalf of the European Union (EU) medicines regulatory network.